Verfahren zur Hochpräzisen Krebszellenunterscheidung und Systeme dafür

EP4782813 29. Juli 2026

Anmelder: Becton Dickinson and Company 🇺🇸

Details

Veröffentlichungs-Nr.
EP4782813
Anmeldetag
19. Januar 2026
Veröffentlichung
29. Juli 2026
Rechtsraum
EP
Offizieller Volltext

Abstract

Aspects of the present disclosure include systems for detecting and classifying a cancerous cell in a whole blood sample in a flow stream. Systems according to certain embodiments include a light source configured to irradiate cells of a whole blood sample in a flow stream, a light detection system comprising a photodetector capturing an image of light emitted from the irradiated cells and a processor having memory operably coupled to the processor where the memory includes instructions stored thereon, which when executed by the processor, cause the processor to apply a neural network to the captured image to detect a presence of a cancerous cell in the whole blood sample having a minimum concentration of the cancerous cell and determine a classification of the cancerous cell of a plurality of classifications. In some instances, the neural network is trained using images of a sample tagged with a fluorophore ground truth marker. Methods for using the subject systems to detect and classify cancerous cells in a whole blood sample are also described. Non-transitory computer readable storage media are also provided.

Anmelder

Firma
Becton Dickinson and Company
Land
🇺🇸 USA
🇺🇸 Becton Dickinson

US-amerikanisches Medizintechnikunternehmen mit Sitz in Franklin Lakes, New Jersey. Entwickelt medizinische Geräte, Diagnostiksysteme, Injektions- und Infusionstechnik sowie Laborausrüstung für Kliniken und Forschung.

3.997 Patente in unserer Datenbank

Vertreten von

Noch Fragen?

Wir helfen Ihnen gerne weiter. Schreiben Sie uns einfach.

Kontakt aufnehmen